BB
BridgeBio Oncology Therapeutics Inc. (BBOT)
NASDAQ·Healthcare·Biotechnology
$8.84
+0.57%
Mkt Cap $702.69M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (8 analysts)
$21.67
Range $18.00 – $24.00
Implied Upside
+145.1%
Consensus $21.67 vs current $8.84